Xiuliang Cui

3.1k total citations · 2 hit papers
34 papers, 2.0k citations indexed

About

Xiuliang Cui is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiuliang Cui has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Xiuliang Cui's work include Bioinformatics and Genomic Networks (8 papers), Liver physiology and pathology (5 papers) and MicroRNA in disease regulation (5 papers). Xiuliang Cui is often cited by papers focused on Bioinformatics and Genomic Networks (8 papers), Liver physiology and pathology (5 papers) and MicroRNA in disease regulation (5 papers). Xiuliang Cui collaborates with scholars based in China, United States and Czechia. Xiuliang Cui's co-authors include Hongyang Wang, Wen Sun, Jin Ding, Daimin Xiang, Beifang Ning, Xiaofeng Li, Mingyang Xia, Wenru Su, Wen Wen and Hao Tang and has published in prestigious journals such as Nature Communications, Bioinformatics and Gastroenterology.

In The Last Decade

Xiuliang Cui

32 papers receiving 2.0k citations

Hit Papers

Immune cell profiling of COVID-19 patients in the recover... 2020 2026 2022 2024 2020 2024 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuliang Cui China 16 1.1k 762 432 415 284 34 2.0k
Rita Humeniuk United States 14 818 0.7× 541 0.7× 247 0.6× 178 0.4× 647 2.3× 31 1.8k
Paweł K. Mazur United States 22 1.6k 1.4× 475 0.6× 114 0.3× 177 0.4× 805 2.8× 40 2.5k
Liyong Zhang China 24 1.4k 1.3× 374 0.5× 70 0.2× 289 0.7× 430 1.5× 83 2.1k
Xing Fan China 23 563 0.5× 184 0.2× 98 0.2× 330 0.8× 157 0.6× 80 1.4k
James E. Esplen United States 11 945 0.9× 219 0.3× 67 0.2× 321 0.8× 392 1.4× 11 1.7k
Afshin Derakhshani Iran 26 764 0.7× 424 0.6× 159 0.4× 655 1.6× 812 2.9× 70 2.0k
Guanhua Song China 19 829 0.7× 386 0.5× 80 0.2× 516 1.2× 284 1.0× 43 1.4k
Andreas S. Barth United States 31 1.3k 1.2× 225 0.3× 225 0.5× 353 0.9× 686 2.4× 81 3.0k
Karl‐Henning Kalland Norway 34 1.5k 1.4× 520 0.7× 108 0.3× 341 0.8× 658 2.3× 81 2.5k

Countries citing papers authored by Xiuliang Cui

Since Specialization
Citations

This map shows the geographic impact of Xiuliang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuliang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuliang Cui more than expected).

Fields of papers citing papers by Xiuliang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuliang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuliang Cui. The network helps show where Xiuliang Cui may publish in the future.

Co-authorship network of co-authors of Xiuliang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuliang Cui. A scholar is included among the top collaborators of Xiuliang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuliang Cui. Xiuliang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Zhi, Xu Zhang, Xiuliang Cui, et al.. (2025). Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co‐Inhibition of TGF ‐β and GSK ‐3 Signalling. Liver International. 45(7). e70187–e70187.
2.
Cui, Xiuliang, et al.. (2024). Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis. Journal of Nanobiotechnology. 22(1). 541–541. 4 indexed citations
3.
Song, Bin, Peilin Zhang, Zhi Zhong, et al.. (2023). PC3T: a signature-driven predictor of chemical compounds for cellular transition. Communications Biology. 6(1). 989–989. 1 indexed citations
4.
Liu, Fuchen, Yu Han, Jing Fu, et al.. (2023). Balance of Gata3 and Ramp2 in hepatocytes regulates hepatic vascular reconstitution in postoperative liver regeneration. Journal of Hepatology. 80(2). 309–321. 7 indexed citations
5.
Wang, Xiang, Chunliang Liu, Jianan Chen, et al.. (2022). Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. Cell Discovery. 8(1). 101–101. 39 indexed citations
6.
Pan, Yufei, Can Chen, Xiuliang Cui, et al.. (2022). Androgens drive sexual dimorphism in liver metastasis by promoting hepatic accumulation of neutrophils. Cell Reports. 39(12). 110987–110987. 16 indexed citations
7.
Cui, Xiuliang, Lu Han, Gongbo Fu, et al.. (2022). Immune index: A gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma. Pharmacological Research. 187. 106583–106583. 4 indexed citations
8.
Zhou, Tengfei, Shichao Li, Daimin Xiang, et al.. (2020). m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduction and Targeted Therapy. 5(1). 296–296. 100 indexed citations
9.
Lv, Hongwei, Guishuai Lv, Guo‐Qing Jiang, et al.. (2020). NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion. Cell Metabolism. 33(1). 110–127.e5. 179 indexed citations
10.
Li, Ying, Yaping Dong, You‐Wen Qian, et al.. (2020). Identification of important genes and drug repurposing based on clinical-centered analysis across human cancers. Acta Pharmacologica Sinica. 42(2). 282–289. 4 indexed citations
11.
Wen, Wen, Wenru Su, Hao Tang, et al.. (2020). Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing. Cell Discovery. 6(1). 31–31. 524 indexed citations breakdown →
12.
Cui, Xiuliang, Yang Liu, Wen Sun, et al.. (2020). Comprehensive analysis of miRNA-gene regulatory network with clinical significance in human cancers. Science China Life Sciences. 63(8). 1201–1212. 6 indexed citations
13.
Xiang, Daimin, Wen Sun, Tengfei Zhou, et al.. (2019). Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance. Gut. 68(10). 1858–1871. 97 indexed citations
14.
Cheng, Zhuo, Zhiying He, Yongchao Cai, et al.. (2018). Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. Cell Research. 29(2). 124–135. 61 indexed citations
15.
Xiang, Daimin, Wen Sun, Beifang Ning, et al.. (2017). The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut. 67(9). 1704–1715. 181 indexed citations
16.
Liu, Jiao, Xiuliang Cui, Jinhua Jiang, et al.. (2017). Uncoordinated expression of DNA methylation-related enzymes in human cancer. Epigenetics & Chromatin. 10(1). 61–61. 6 indexed citations
17.
Wang, Xue, Wen Sun, Weifeng Shen, et al.. (2016). Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. Journal of Hepatology. 64(6). 1283–1294. 255 indexed citations
18.
Cui, Xiuliang, et al.. (2015). Network fingerprint: a knowledge-based characterization of biomedical networks. Scientific Reports. 5(1). 13286–13286. 9 indexed citations
19.
Xu, Yiran, Xiaorui Cheng, Xiuliang Cui, et al.. (2015). Effects of 5-h multimodal stress on the molecules and pathways involved in dendritic morphology and cognitive function. Neurobiology of Learning and Memory. 123. 225–238. 7 indexed citations
20.
Cheng, Xiaorui, Xiuliang Cui, Yue Zheng, et al.. (2013). Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model. Frontiers in Aging Neuroscience. 5. 65–65. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026